1. Home
  2. IMAB vs GRWG Comparison

IMAB vs GRWG Comparison

Compare IMAB & GRWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • GRWG
  • Stock Information
  • Founded
  • IMAB 2014
  • GRWG 2008
  • Country
  • IMAB United States
  • GRWG United States
  • Employees
  • IMAB N/A
  • GRWG N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • GRWG RETAIL: Building Materials
  • Sector
  • IMAB Health Care
  • GRWG Consumer Discretionary
  • Exchange
  • IMAB Nasdaq
  • GRWG Nasdaq
  • Market Cap
  • IMAB 87.2M
  • GRWG 82.3M
  • IPO Year
  • IMAB 2020
  • GRWG N/A
  • Fundamental
  • Price
  • IMAB $0.99
  • GRWG $1.48
  • Analyst Decision
  • IMAB Strong Buy
  • GRWG Hold
  • Analyst Count
  • IMAB 3
  • GRWG 5
  • Target Price
  • IMAB $8.00
  • GRWG $2.75
  • AVG Volume (30 Days)
  • IMAB 354.5K
  • GRWG 575.6K
  • Earning Date
  • IMAB 03-13-2025
  • GRWG 03-12-2025
  • Dividend Yield
  • IMAB N/A
  • GRWG N/A
  • EPS Growth
  • IMAB N/A
  • GRWG N/A
  • EPS
  • IMAB N/A
  • GRWG N/A
  • Revenue
  • IMAB $3,313,984.00
  • GRWG $200,882,000.00
  • Revenue This Year
  • IMAB N/A
  • GRWG N/A
  • Revenue Next Year
  • IMAB N/A
  • GRWG N/A
  • P/E Ratio
  • IMAB N/A
  • GRWG N/A
  • Revenue Growth
  • IMAB N/A
  • GRWG N/A
  • 52 Week Low
  • IMAB $0.84
  • GRWG $1.35
  • 52 Week High
  • IMAB $2.00
  • GRWG $3.38
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 43.19
  • GRWG 53.37
  • Support Level
  • IMAB $1.03
  • GRWG $1.35
  • Resistance Level
  • IMAB $1.10
  • GRWG $1.46
  • Average True Range (ATR)
  • IMAB 0.06
  • GRWG 0.07
  • MACD
  • IMAB -0.01
  • GRWG 0.01
  • Stochastic Oscillator
  • IMAB 7.58
  • GRWG 91.30

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About GRWG GrowGeneration Corp.

GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.

Share on Social Networks: